Literature DB >> 25028484

A mouse model of human congenital heart disease: high incidence of diverse cardiac anomalies and ventricular noncompaction produced by heterozygous Nkx2-5 homeodomain missense mutation.

Hassan Ashraf1, Lagnajeet Pradhan2, Eileen I Chang1, Ryota Terada1, Nicole J Ryan1, Laura E Briggs1, Rajib Chowdhury1, Miguel A Zárate1, Yukiko Sugi3, Hyun-Joo Nam2, D Woodrow Benson4, Robert H Anderson5, Hideko Kasahara1.   

Abstract

BACKGROUND: Heterozygous human mutations of NKX2-5 are highly penetrant and associated with varied congenital heart defects. The heterozygous knockout of murine Nkx2-5, in contrast, manifests less profound cardiac malformations, with low disease penetrance. We sought to study this apparent discrepancy between human and mouse genetics. Because missense mutations in the NKX2-5 homeodomain (DNA-binding domain) are the most frequently reported type of human mutation, we replicated this genetic defect in a murine knockin model. METHODS AND
RESULTS: We generated a murine model in a 129/Sv genetic background by knocking-in an Nkx2-5 homeodomain missense mutation previously identified in humans. The mutation was located at homeodomain position 52Arg→Gly (R52G). All the heterozygous neonatal Nkx2-5(+/R52G) mice demonstrated a prominent trabecular layer in the ventricular wall, so called noncompaction, along with diverse cardiac anomalies, including atrioventricular septal defects, Ebstein malformation of the tricuspid valve, and perimembranous and muscular ventricular septal defects. In addition, P10 Nkx2-5(+/R52G) mice demonstrated atrial sepal anomalies, with significant increase in the size of the interatrial communication and fossa ovalis, and decrease in the length of the flap valve compared with control Nkx2-5(+/+) or Nkx2-5(+/-) mice.
CONCLUSIONS: The results of our study demonstrate that heterozygous missense mutation in the murine Nkx2-5 homeodomain (R52G) is highly penetrant and result in pleiotropic cardiac effects. Thus, in contrast to heterozygous Nkx2-5 knockout mice, the effects of the heterozygous knockin mimic findings in humans with heterozygous missense mutation in NKX2-5 homeodomain.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  congenital; genetics

Mesh:

Substances:

Year:  2014        PMID: 25028484      PMCID: PMC4140955          DOI: 10.1161/CIRCGENETICS.113.000281

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  52 in total

1.  Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease.

Authors:  B Stallmeyer; H Fenge; U Nowak-Göttl; E Schulze-Bahr
Journal:  Clin Genet       Date:  2010-12       Impact factor: 4.438

2.  Differential role of Nkx2-5 in activation of the atrial natriuretic factor gene in the developing versus failing heart.

Authors:  Sonisha A Warren; Ryota Terada; Laura E Briggs; Colleen T Cole-Jeffrey; Wei-Ming Chien; Tsugio Seki; Ellen O Weinberg; Thomas P Yang; Michael T Chin; Jörg Bungert; Hideko Kasahara
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

3.  Novel NKX2-5 mutations in patients with familial atrial septal defects.

Authors:  Xing-Yuan Liu; Juan Wang; Yi-Qing Yang; Yang-Yang Zhang; Xiao-Zhong Chen; Wei Zhang; Xiao-Zhou Wang; Jing-Hao Zheng; Yi-Han Chen
Journal:  Pediatr Cardiol       Date:  2010-12-25       Impact factor: 1.655

4.  Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation.

Authors:  Ryota Terada; Sonisha Warren; Jonathan T Lu; Kenneth R Chien; Andy Wessels; Hideko Kasahara
Journal:  Cardiovasc Res       Date:  2011-02-01       Impact factor: 10.787

Review 5.  The changing epidemiology of congenital heart disease.

Authors:  Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder
Journal:  Nat Rev Cardiol       Date:  2010-11-02       Impact factor: 32.419

6.  Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.

Authors:  D W Benson; G M Silberbach; A Kavanaugh-McHugh; C Cottrill; Y Zhang; S Riggs; O Smalls; M C Johnson; M S Watson; J G Seidman; C E Seidman; J Plowden; J D Kugler
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

7.  Formation of the tricuspid valve in the human heart.

Authors:  W H Lamers; S Virágh; A Wessels; A F Moorman; R H Anderson
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

8.  Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005.

Authors:  Helen Dolk; Maria Loane; Ester Garne
Journal:  Circulation       Date:  2011-02-14       Impact factor: 29.690

9.  Novel NKX2-5 mutations responsible for congenital heart disease.

Authors:  J Wang; X Y Liu; Y Q Yang
Journal:  Genet Mol Res       Date:  2011-11-29

10.  Lineage and morphogenetic analysis of the cardiac valves.

Authors:  Frederik J de Lange; Antoon F M Moorman; Robert H Anderson; Jörg Männer; Alexandre T Soufan; Corrie de Gier-de Vries; Michael D Schneider; Sandra Webb; Maurice J B van den Hoff; Vincent M Christoffels
Journal:  Circ Res       Date:  2004-08-05       Impact factor: 17.367

View more
  23 in total

Review 1.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

Review 2.  Defects in Trabecular Development Contribute to Left Ventricular Noncompaction.

Authors:  Caroline Choquet; Robert G Kelly; Lucile Miquerol
Journal:  Pediatr Cardiol       Date:  2019-07-24       Impact factor: 1.655

3.  Point mutations in murine Nkx2-5 phenocopy human congenital heart disease and induce pathogenic Wnt signaling.

Authors:  Milena B Furtado; Julia C Wilmanns; Anjana Chandran; Joelle Perera; Olivia Hon; Christine Biben; Taylor J Willow; Hieu T Nim; Gurpreet Kaur; Stephanie Simonds; Qizhu Wu; David Willians; Ekaterina Salimova; Nicolas Plachta; James M Denegre; Stephen A Murray; Diane Fatkin; Michael Cowley; James T Pearson; David Kaye; Mirana Ramialison; Richard P Harvey; Nadia A Rosenthal; Mauro W Costa
Journal:  JCI Insight       Date:  2017-03-23

4.  Tricuspid Atresia with Non-compaction: An Early Experience with Implications for Surgical Palliation.

Authors:  Hoang H Nguyen; Rabia Khan; Norman H Silverman; Gautam K Singh
Journal:  Pediatr Cardiol       Date:  2016-12-10       Impact factor: 1.655

5.  Mouse Model of Human Congenital Heart Disease: Progressive Atrioventricular Block Induced by a Heterozygous Nkx2-5 Homeodomain Missense Mutation.

Authors:  Rajib Chowdhury; Hassan Ashraf; Michelle Melanson; Yohei Tanada; Minh Nguyen; Michael Silberbach; Hiroko Wakimoto; D Woodrow Benson; Robert H Anderson; Hideko Kasahara
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-07-30

6.  Potential Common Pathogenic Pathways for the Left Ventricular Noncompaction Cardiomyopathy (LVNC).

Authors:  Ying Liu; Hanying Chen; Weinian Shou
Journal:  Pediatr Cardiol       Date:  2018-05-15       Impact factor: 1.655

Review 7.  In Vivo and In Vitro Genetic Models of Congenital Heart Disease.

Authors:  Uddalak Majumdar; Jun Yasuhara; Vidu Garg
Journal:  Cold Spring Harb Perspect Biol       Date:  2021-04-01       Impact factor: 10.005

8.  Single-Cell Resolution of Temporal Gene Expression during Heart Development.

Authors:  Daniel M DeLaughter; Alexander G Bick; Hiroko Wakimoto; David McKean; Joshua M Gorham; Irfan S Kathiriya; John T Hinson; Jason Homsy; Jesse Gray; William Pu; Benoit G Bruneau; J G Seidman; Christine E Seidman
Journal:  Dev Cell       Date:  2016-11-10       Impact factor: 12.270

Review 9.  Genetics of Cardiac Developmental Disorders: Cardiomyocyte Proliferation and Growth and Relevance to Heart Failure.

Authors:  Lisa Wilsbacher; Elizabeth M McNally
Journal:  Annu Rev Pathol       Date:  2016-02-24       Impact factor: 23.472

10.  An eIF3a gene mutation dysregulates myocardium growth with left ventricular noncompaction via the p-ERK1/2 pathway.

Authors:  Mei Ge; Xuehan Bai; Aoyi Liu; Lingjuan Liu; Jie Tian; Tiewei Lu
Journal:  Genes Dis       Date:  2020-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.